Captrust Financial Advisors Homology Medicines, Inc. Transaction History

Captrust Financial Advisors

  • $33 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 16, 2022
BUY
$1.39 - $3.12 $278 - $624
200 Added 16.67%
1,400 $3,000
Q3 2021

Nov 16, 2021
BUY
$6.01 - $8.71 $300 - $435
50 Added 4.35%
1,200 $9,000
Q2 2021

Aug 16, 2021
BUY
$6.02 - $9.64 $6,020 - $9,640
1,000 Added 666.67%
1,150 $8,000
Q1 2021

May 17, 2021
BUY
$9.17 - $14.8 $1,375 - $2,220
150 New
150 $1,000

Others Institutions Holding FIXX

# of Institutions
3
Shares Held
66.2K
Call Options Held
0
Put Options Held
0
View Full List

About Homology Medicines, Inc.

FIXX Quotes by TradingView
  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email